Cited by 1,513Alzheimer's disease research and treatmentsDementia and Cognitive Impairment ResearchAmyotrophic Lateral Sclerosis Research

The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.

A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N–terminus of β–amyloid

Mullan, Mike, Crawford, Fiona, Axelman, Karin, Houlden, Henry, Lilius, Lena, Winblad, Bengt, Lannfelt, Lars·1992·Nature Genetics

DOI 10.1038/ng0892-345

Open this paper in CoChat — free account

Abstract

Mutations at codon 717 in exon 17 of the beta-amyloid precursor protein (APP) gene have previously been shown to segregate with early onset Alzheimer's disease in some families. We have identified a double mutation at codons 670 and 671 (APP 770 transcript) in exon 16 which co-segregates with the disease in two large (probably related) early-onset Alzheimer's disease families from Sweden. Two base pair transversions (G to T, A to C) from the normal sequence predict Lys to Asn and Met to Leu amino acid substitutions at codons 670 and 671 of the APP transcript. This mutation occurs at the amino terminal of beta-amyloid and may be pathogenic because it occurs at or close to the endosomal/lysosomal cleavage site of the molecule. Thus, pathogenic mutations in APP frame the beta-amyloid sequence.

Integrity signals

Registry

Crossref · 10.1038/ng0892-345

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Clinical diagnosis of Alzheimer's disease: Report of the NINCDS‐ADRDA Work Group* under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
Alzheimer's disease: the amyloid cascade hypothesis
Hardy, J. A., & Higgins, G. A. (1992) · Science · doi:10.1126/science.1566067 · Cited by 7,484
Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein
Glenner, G. G., & Wong, C. W. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(84)80190-4 · Cited by 5,404
Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease
Goate, A., Chartier-Harlin, M.-C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L., et al. (1991) · Nature · doi:10.1038/349704a0 · Cited by 4,659
Self-citation
Amyloid plaque core protein in Alzheimer disease and Down syndrome.
Masters, C. L., Simms, G., Weinman, N. A., Multhaup, G., McDonald, B. L., & Beyreuther, K. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.12.4245 · Cited by 4,431
The molecular pathology of Alzheimer's disease
Selkoe, D. J. (1991) · Neuron · doi:10.1016/0896-6273(91)90052-2 · Cited by 2,708
Cleavage of Amyloid β Peptide During Constitutive Processing of Its Precursor
Esch, F. S., Keim, P. S., Beattie, E. C., Blacher, R. W., Culwell, A. R., Oltersdorf, T., McClure, D., & Ward, P. J. (1990) · Science · doi:10.1126/science.2111583 · Cited by 1,403
Mutation of the Alzheimer's Disease Amyloid Gene in Hereditary Cerebral Hemorrhage, Dutch Type
Levy, E., Carman, M. D., Fernandez-Madrid, I. J., Power, M. D., Lieberburg, I. M., van Duinen, S. G., Bots, G. T. A. M., Luyendijk, W., & Frangione, B. (1990) · Science · doi:10.1126/science.2111584 · Cited by 1,399
Early-onset Alzheimer's disease caused by mutations at codon 717 of the β-amyloid precursor protein gene
Chartier-Harlin, M.-C., Crawford, F., Houlden, H., Warren, A., Hughes, D., Fidani, L., Goate, A., Rossor, M., Roques, P., Hardy, J., et al. (1991) · Nature · doi:10.1038/353844a0 · Cited by 1,214
Self-citation
A mutation in the Amyloid Precursor Protein Associated with Hereditary Alzheimer's Disease
Murrell, J. R., Farlow, M. R., Ghetti, B. F., & Benson, M. D. (1991) · Science · doi:10.1126/science.1925564 · Cited by 1,142

Show all 22 references

Research works printed but not linked: 2

Hardy, J. et al. Lancet 337, 1342–1343 (1991).
Weeks, D.E., Ott, J. & Lathrop, G M. Am. J. hum. Genet. 47(3), A204 (1990).

Sorted by citations

Items 401–500 of 1,002

Amyloid β-Peptide Increases Mitochondria-Endoplasmic Reticulum Contact Altering Mitochondrial Function and Autophagosome Formation in Alzheimer’s Disease-Related Models
Leal, N. S., Dentoni, G., Schreiner, B., Naia, L., Piras, A., Graff, C., Cattaneo, A., Meli, G., Hamasaki, M., Nilsson, P., et al. (2020) · Cells · doi:10.3390/cells9122552 · Cited by 77
Plasma biomarker profiles in autosomal dominant Alzheimer’s disease
Johansson, C., Þórðardóttir, S., Laffita‐Mesa, J. M., Rodriguez‐Vieitez, E., Zetterberg, H., Blennow, K., & Graff, C. (2022) · Brain · doi:10.1093/brain/awac399 · Cited by 80
New evolutions in the BACE1 inhibitor field from 2014 to 2018
Hsiao, C., Rombouts, F. J. R., & Gijsen, H. J. M. (2019) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2018.12.049 · Cited by 76
Circular RNA Encoded Amyloid Beta peptides—A Novel Putative Player in Alzheimer’s Disease
Mo, D., Li, X., Raabe, C. A., Rozhdestvensky, T. S., Skryabin, B. V., & Brosius, J. (2020) · Cells · doi:10.3390/cells9102196 · Cited by 74
β-Secretase: its biology as a therapeutic target in diseases
Wang, H., Li, R., & Shen, Y. (2013) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2013.01.008 · Cited by 69
Behavioral and neural network abnormalities in human APP transgenic mice resemble those of App knock-in mice and are modulated by familial Alzheimer's disease mutations but not by inhibition of BACE1
Johnson, E. C. B., Ho, K., Yu, G.-Q., Das, M., Sanchez, P. E., Djukic, B., Lopez, I., Yu, X., Gill, M., Zhang, W., et al. (2020) · Molecular Neurodegeneration · doi:10.1186/s13024-020-00393-5 · Cited by 73
Lack of BACE1 S-palmitoylation reduces amyloid burden and mitigates memory deficits in transgenic mouse models of Alzheimer’s disease
Andrew, R. J., Fernandez, C. G., Stanley, M., Jiang, H., Nguyen, P. A. H., Rice, R. C., Buggia-Prévot, V., Rossi, P. D., Vetrivel, K. S., Lamb, R., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1708568114 · Cited by 74
Genetic risk factors in Alzheimer's disease.
Tilley, L. A., Morgan, K., & Kalsheker, N. A. (1998) · Molecular Pathology · doi:10.1136/mp.51.6.293 · Cited by 72
Tauroursodeoxycholic acid modulates p53‐mediated apoptosis in Alzheimer's disease mutant neuroblastoma cells
Ramalho, R. M., Borralho, P. M., Castro, R. E., Solá, S., Steer, C. J., & Rodrigues, C. M. P. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04007.x · Cited by 71
Identification of a peptide recognizing cerebrovascular changes in mouse models of Alzheimer’s disease
Mann, A. P., Scodeller, P., Hussain, S., Braun, G. B., Mölder, T., Toome, K., Ambasudhan, R., Teesalu, T., Lipton, S. A., & Ruoslahti, E. I. (2017) · Nature Communications · doi:10.1038/s41467-017-01096-0 · Cited by 72
Reactive astrocytes as treatment targets in Alzheimer's disease—Systematic review of studies using the APPswePS1dE9 mouse model
Smit, T., Deshayes, N. A. C., Borchelt, D. R., Kamphuis, W., Middeldorp, J., & Hol, E. M. (2021) · Glia · doi:10.1002/glia.23981 · Cited by 71
Protein Phosphorylation and APP Metabolism
Silva, E. F. D. C. E., & Silva, O. A. B. D. C. E. (2003) · Neurochemical Research · doi:10.1023/a:1025630627319 · Cited by 70
miR-23b-3p rescues cognition in Alzheimer’s disease by reducing tau phosphorylation and apoptosis via GSK-3β signaling pathways
Jiang, H., Liu, J., Guo, S., Zeng, L., Cai, Z., Zhang, J., Wang, L., Li, Z., & Liu, R. (2022) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2022.04.008 · Cited by 72
Neuronal Protein Tyrosine Phosphatase 1B Hastens Amyloid β-Associated Alzheimer's Disease in Mice
Ricke, K. M., Cruz, S. A., Qin, Z., Farrokhi, K., Sharmin, F., Zhang, L., ZASLOFF, M. A., Stewart, A. F. R., & Chen, H. (2020) · Journal of Neuroscience · doi:10.1523/jneurosci.2120-19.2019 · Cited by 71
High levels of circulating beta-amyloid peptide do not cause cerebral beta-amyloidosis in transgenic mice.
Fukuchi, K., Ho, L., Younkin, S. G., Kunkel, D. D., Ogburn, C. E., LeBoeuf, R. C., Furlong, C. E., Deeb, S. S., Nochlin, D., Węgiel, J., et al. (1996) · Europe PMC (PubMed Central) · Cited by 69
Decreased phosphatidylethanolamine binding protein expression correlates with Aβ accumulation in the Tg2576 mouse model of Alzheimer's disease
George, A. J., Holsinger, R. M. D., McLean, C., Tan, S., Scott, H. S., Cardamone, T., Cappai, R., Masters, C. L., & Li, Q. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.03.014 · Cited by 69
Neuropeptide alterations in the hippocampal formation and cortex of transgenic mice overexpressing β-amyloid precursor protein (APP) with the Swedish double mutation (APP23)
Diez, M., Danner, S., Frey, P., Sommer, B., Staufenbiel, M., Wiederhold, K., & Hökfelt, T. G. M. (2003) · Neurobiology of Disease · doi:10.1016/j.nbd.2003.08.003 · Cited by 70
Increasing cerebrospinal fluid tau levels in a subgroup of Alzheimer patients with apolipoprotein E allele ϵ4 during 14 months follow-up
Blomberg, M. E., Jensen, M., Basun, H., Lannfelt, L., & Wahlund, L. (1996) · Neuroscience Letters · doi:10.1016/0304-3940(96)12905-0 · Cited by 69
Self-citation
The Protease Inhibitor, MG132, Blocks Maturation of the Amyloid Precursor Protein Swedish Mutant Preventing Cleavage by β-Secretase
Steinhilb, M. L., Turner, R. S., & Gaut, J. R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008793200 · Cited by 69
Prion Protein Interacts with BACE1 Protein and Differentially Regulates Its Activity toward Wild Type and Swedish Mutant Amyloid Precursor Protein
Jarosz-Griffiths, H., Whitehouse, I. J., Baybutt, H. N., Brown, D., Kellett, K. A. B., Jackson, C. D., Turner, A. J., Piccardo, P., Manson, J. C., & Hooper, N. M. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.278556 · Cited by 72
BACE1: A Key Regulator in Alzheimer’s Disease Progression and Current Development of its Inhibitors
Patel, S., Bansoad, A. V., Singh, R., & Khatik, G. L. (2021) · Current Neuropharmacology · doi:10.2174/1570159x19666211201094031 · Cited by 69
Microinjection of synthetic amyloid beta-protein in monkey cerebral cortex fails to produce acute neurotoxicity.
Podlisny, M. B., Stephenson, D. T., Frosch, M. P., Tolan, D. R., Lieberburg, I. M., Clemens, J. A., & Selkoe, D. J. (1993) · PubMed · Cited by 68
Evidence that the APOE locus influences rate of disease progression in late onset familial Alzheimer's Disease but is not causative
Bennett, C., Crawford, F., Osborne, A., Diaz, P., Hoyne, J., Lopez, R., Roques, P., Duara, R., Rossor, M., & Mullan, M. (1995) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320600102 · Cited by 67
Self-citation
Novel rat Alzheimer's disease models based on AAV-mediated gene transfer to selectively increase hippocampal Aβ levels
Lawlor, P. A., Bland, R. J., Das, P., Price, R. W., Holloway, V., Smithson, L., Dicker, B. L., During, M. J., Young, D., & Golde, T. E. (2007) · Molecular Neurodegeneration · doi:10.1186/1750-1326-2-11 · Cited by 67
The role of APP and APLP for synaptic transmission, plasticity, and network function: lessons from genetic mouse models
Körte, M., Herrmann, U., Zhang, X., & Draguhn, A. (2011) · Experimental Brain Research · doi:10.1007/s00221-011-2894-6 · Cited by 69
Kynurenines, neurodegeneration and Alzheimer’s disease
Kincses, Z. T., Toldi, J., & Vécsei, L. (2010) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2010.01123.x · Cited by 70
Confirmation of association between the e4 allele of apolipoprotein E and Alzheimer's disease.
Liddell, M. B., Williams, J. H., Bayer, A. J., Kaiser, F. E., & Owen, M. J. (1994) · Journal of Medical Genetics · doi:10.1136/jmg.31.3.197 · Cited by 67
Presenilin-mediated cleavage of APP regulates synaptotagmin-7 and presynaptic plasticity
Barthet, G., Jordá-Siquier, T., Rumi, J., Bernadou, F., Müller, U. C., & Mulle, C. (2018) · Nature Communications · doi:10.1038/s41467-018-06813-x · Cited by 69
Neuronal Nicotinic Receptor Deficits in Alzheimer Patients with the Swedish Amyloid Precursor Protein 670/671 Mutation
Marutle, A., Warpman, U., Bogdanović, N., Lannfelt, L., & Nordberg, A. K. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0721161.x · Cited by 66
Self-citation
Clinical studies in Alzheimer patients with positron emission tomography
Nordberg, A. K. (1993) · Behavioural Brain Research · doi:10.1016/0166-4328(93)90138-g · Cited by 66
Molecular genetics in neurology
Martin, J. B. (1993) · Annals of Neurology · doi:10.1002/ana.410340603 · Cited by 66
Novel Anti-Alzheimer’s Therapeutic Molecules Targeting Amyloid Precursor Protein Processing
Uddin, M. S., Kabir, M. T., Jeandet, P., Mathew, B., Ashraf, G. M., Perveen, A., Bin-Jumah, M. N., Mousa, S. A., & Abdel‐Daim, M. M. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/7039138 · Cited by 67
APP intracellular domain derived from amyloidogenic β- and γ-secretase cleavage regulates neprilysin expression
Grimm, M. O. W., Mett, J., Stahlmann, C. P., Grösgen, S., Haupenthal, V. J., Blümel, T., Hundsdörfer, B., Zimmer, V. C., Mylonas, N. T., Tanila, H., et al. (2015) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2015.00077 · Cited by 68
The Ras-related GTP-binding Protein, Rab1B, Regulates Early Steps in Exocytic Transport and Processing of β-Amyloid Precursor Protein
Dugan, J. M., deWit, C., McConlogue, L., & Maltese, W. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.18.10982 · Cited by 65
Selective Nicotinic Receptor Consequences in APPSWE Transgenic Mice
Bednar, I., Paterson, D., Marutle, A., Pham, T. M., Svedberg, M. M., Hellström‐Lindahl, E., Mousavi, M. T., COURT, J. A., Morris, C. M., Perry, E. K., et al. (2002) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.2002.1112 · Cited by 65
Elimination of the Class A Scavenger Receptor Does Not Affect Amyloid Plaque Formation or Neurodegeneration in Transgenic Mice Expressing Human Amyloid Protein Precursors
Huang, F., Buttini, M., Wyss-Coray, T., McConlogue, L., Kodama, T., Pitas, R. E., & Mucke, L. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65489-2 · Cited by 49
Processing of the Pre‐β‐amyloid Protein by Cathepsin d is Enhanced by a Familial Alzheimer's Disease Mutation
Dreyer, R. N., Bausch, K. M., Fracasso, P., Hammond, L. J., Wunderlich, D. A., Wirak, D. O., Davis, G. L., Brini, C. M., Buckholz, T. M., König, G., et al. (1994) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1994.00265.x · Cited by 67
Tauopathies: recent insights into old diseases.
Delacourte, A. (2005) · PubMed · Cited by 65
Amyloid and Alzheimer's Disease: Inside and Out
Tam, J. H. K., & Pasternak, S. (2012) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100013408 · Cited by 64
M344 promotes nonamyloidogenic amyloid precursor protein processing while normalizing Alzheimer’s disease genes and improving memory
Volmar, C., Salah-Uddin, H., Janczura, K. J., Halley, P., Lambert, G., Wodrich, A. P. K., Manoah, S., Patel, N. H., Sartor, G. C., Mehta, N., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1707544114 · Cited by 67
CRISPR-Cas9: A Promising Genome Editing Therapeutic Tool for Alzheimer’s Disease—A Narrative Review
Barman, N. C., Khan, M. N. M., Islam, M., Nain, Z., Roy, R. K., Haque, A., & BARMAN, S. K. (2020) · Neurology and Therapy · doi:10.1007/s40120-020-00218-z · Cited by 65
Neuronal neprilysin overexpression is associated with attenuation of Aβ-related spatial memory deficit
Poirier, R., Wolfer, D. P., Welzl, H., Tracy, J., Galsworthy, M. J., Nitsch, R. M., & Mohajeri, M. H. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.08.003 · Cited by 64
The proteins BACE1 and BACE2 and β-secretase activity in normal and Alzheimer's disease brain
Stockley, J. H., & O’Neill, C. (2007) · Biochemical Society Transactions · doi:10.1042/bst0350574 · Cited by 64
The neurotoxicity of amyloid beta protein in aged primates
McKee, A. C., Kawall, N. W., Schumacher, J. S., & Beal, M. F. (1998) · Amyloid · doi:10.3109/13506129809007283 · Cited by 64
Brain-wide Cas9-mediated cleavage of a gene causing familial Alzheimer’s disease alleviates amyloid-related pathologies in mice
Duan, Y., Tao, Y., Qu, Z., Chen, Y., Miranda, A., Zhou, X., Lok, K.-C., Chen, Y., Fu, A. K. Y., Gradinaru, V., et al. (2021) · Nature Biomedical Engineering · doi:10.1038/s41551-021-00759-0 · Cited by 64
Lewy body and Alzheimer pathology in a family with the amyloid-β precursor protein APP717 gene mutation
Rosenberg, C. K., Pericak‐Vance, M. A., Saunders, A. M., Gilbert, J. R., Gaskell, P. C., & Hulette, C. M. (2000) · Acta Neuropathologica · doi:10.1007/s004019900155 · Cited by 63
Clinical, Neuropathologic, and Biochemical Profile of the Amyloid Precursor Protein I716F Mutation
Guardia‐Laguarta, C., Pera, M., Clarimón, J., Molinuevo, J. L., Sánchez‐Valle, R., Lladó, A., Coma, M., Gómez‐Isla, T., Blesa, R., Ferrer, I., et al. (2009) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181c6b84d · Cited by 64
Autocatalytic amplification of Alzheimer-associated Aβ42 peptide aggregation in human cerebrospinal fluid
Frankel, R., Törnquist, M., Meisl, G., Hansson, O., Andréasson, U., Zetterberg, H., Blennow, K., Frohm, B., Cedervall, T., Knowles, T. P. J., et al. (2019) · Communications Biology · doi:10.1038/s42003-019-0612-2 · Cited by 63
The Chondroitin Sulfate Attachment Site of Appican Is Formed by Splicing Out Exon 15 of the Amyloid Precursor Gene
Pangalos, M. N., Efthimiopoulos, S., Shioi, J., & Robakis, N. K. R. K. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.18.10388 · Cited by 63
Basolateral Secretion of Amyloid Precursor Protein in Madin-Darby Canine Kidney Cells Is Disturbed by Alterations of Intracellular pH and by Introducing a Mutation Associated with Familial Alzheimer's Disease
Strooper, B. D., Craessaerts, K., Dewachter, I., Moechars, D., Greenberg, B., LEUVEN, F. V., & BERGHE, H. V. D. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.8.4058 · Cited by 63
Neuropathological Characterization of Mutant Amyloid Precursor Protein Yeast Artificial Chromosome Transgenic Mice
Kulnane, L. S., & Lamb, B. T. (2001) · Neurobiology of Disease · doi:10.1006/nbdi.2001.0446 · Cited by 63
Early Onset Alzheimer’s Disease and Oxidative Stress
Meraz‐Ríos, M. A., Franco-Bocanegra, D., Toral-Ríos, D., & Campos‐Peña, V. (2014) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2014/375968 · Cited by 65
BACE1 Inhibitor Lanabecestat (AZD3293) in a Phase 1 Study of Healthy Japanese Subjects: Pharmacokinetics and Effects on Plasma and Cerebrospinal Fluid Aβ Peptides
Sakamoto, K., Matsuki, S., Matsuguma, K., Yoshihara, T., Uchida, N., Azuma, F., Russell, M., Hughes, G., Haeberlein, S. B., Alexander, R., et al. (2017) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.950 · Cited by 62
AF710B, an M1/sigma‐1 receptor agonist with long‐lasting disease‐modifying properties in a transgenic rat model of Alzheimer's disease
Hall, H., Iulita, M. F., Gubert, P., Aguilar, L. F., Ducatenzeiler, A., Fisher, A., & Cuello, A. C. (2017) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2017.11.009 · Cited by 65
Characterization of the high affinity heparin binding site of the Alzheimer's disease βA4 amyloid precursor protein (APP) and its enhancement by zinc(II)
Maulthaup, G., Mechler, H., & Masters, C. L. (1995) · Journal of Molecular Recognition · doi:10.1002/jmr.300080403 · Cited by 62
βAPP mRNA transcription is increased in cultured fibroblasts from the familial Alzheimer's disease-1 family
Querfurth, H. W., Wijsman, E. M., George‐Hyslop, P. S., & Selkoe, D. J. (1995) · Molecular Brain Research · doi:10.1016/0169-328x(94)00224-3 · Cited by 62
Targets for AD treatment: conflicting messages from γ-secretase inhibitors
Sambamurti, K., Greig, N. H., Utsuki, T., Barnwell, E., Sharma, E., Mazell, C., Bhat, N. R., Kindy, M. S., Lahiri, D. K., & Pappolla, M. A. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07213.x · Cited by 62
The Arctic Alzheimer mutation favors intracellular amyloid‐β production by making amyloid precursor protein less available to α‐secretase
Sahlin, C., Lord, A., Magnusson, K., Englund, H., Almeida, C. G., Greengard, P., Nyberg, F., Gouras, G. K., Lannfelt, L., & Nilsson, L. N. G. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04443.x · Cited by 63
Self-citation
Modeling Alzheimer’s disease: from past to future
Saraceno, C., Musardo, S., Marcello, E. E., Pelucchi, S., & Luca, M. D. (2013) · Frontiers in Pharmacology · doi:10.3389/fphar.2013.00077 · Cited by 62
Rapamycin promotes β-amyloid production via ADAM-10 inhibition
Zhang, S., Salemi, J., Hou, H., Zhu, Y., Mori, T., Giunta, B. N., Obregon, D. F., & Tan, J. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.06.017 · Cited by 62
Is γ-secretase a beneficial inactivating enzyme of the toxic APP C-terminal fragment C99?
Checler, F., Afram, E., Pardossi‐Piquard, R., & Lauritzen, I. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100489 · Cited by 63
Nicotinic Cholinergic Modulation: Galantamine as a Prototype
Woodruff‐Pak, D. S., Lander, C., & Geerts, H. (2002) · CNS Drug Reviews · doi:10.1111/j.1527-3458.2002.tb00237.x · Cited by 62
Genetic Phenotypes of Alzheimer’s Disease: Mechanisms and Potential Therapy
Quan, M., Cao, S., Wang, Q., Wang, S., & Jia, J. (2023) · Phenomics · doi:10.1007/s43657-023-00098-x · Cited by 62
Neuronal Nicotinic Acetylcholine Receptors: Involvement in Alzheimer’s Disease and Schizophrenia
Woodruff‐Pak, D. S., & Gould, T. J. (2002) · Behavioral and Cognitive Neuroscience Reviews · doi:10.1177/1534582302001001002 · Cited by 60
Protease inhibitors as potential disease-modifying therapeutics for Alzheimer’s disease
Beher, D., & Graham, S. L. (2005) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.14.11.1385 · Cited by 61
Retention of the Alzheimer's Amyloid Precursor Fragment C99 in the Endoplasmic Reticulum Prevents Formation of Amyloid β-Peptide
Maltese, W. A., Wilson, S. E., Tan, Y., Suomensaari, S., Sinha, S., Barbour, R., & McConlogue, L. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m007238200 · Cited by 60
Unifying features of systemic and cerebral amyloidosis
Ghiso, J. A., Wısnıewskı, T., & Frangione, B. (1994) · Molecular Neurobiology · doi:10.1007/bf02778007 · Cited by 60
Cdk5 Protein Inhibition and Aβ42 Increase BACE1 Protein Level in Primary Neurons by a Post-transcriptional Mechanism
Sadleir, K. R., & Vassar, R. J. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.333914 · Cited by 59
Docosahexaenoic acid stimulates non‐amyloidogenic APP processing resulting in reduced Aβ levels in cellular models of Alzheimer's disease
Sahlin, C., Pettersson, F. E., Nilsson, L. N. G., Lannfelt, L., & Johansson, A. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05719.x · Cited by 60
Self-citation
Cerebrospinal fluid inhibits Alzheimer β‐amyloid fibril formation in vitro
Wısnıewskı, T., Castaño, E. M., Ghiso, J. A., & Frangione, B. (1993) · Annals of Neurology · doi:10.1002/ana.410340422 · Cited by 60
Two-hybrid system as a model to study the interaction of beta-amyloid peptide monomers.
Hughes, S. R., Goyal, S., Sun, J., Gonzalez‐DeWhitt, P. A., Fortes, M. A., Riedel, N. G., & Sahasrabudhe, S. R. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.5.2065 · Cited by 59
Altered oxidation and signal transduction systems in fibroblasts from Alzheimer patients
Gibson, G. E., Martins, R. N., Blass, J. P., & Gandy, S. (1996) · Life Sciences · doi:10.1016/0024-3205(96)00327-x · Cited by 59
CRISPR-Cas9-Mediated Gene Therapy in Neurological Disorders
Guan, L., Han, Y., Yang, C., Lu, S., Du, J., Li, H., & Lin, J. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02638-w · Cited by 58
Clinical Genetics of Alzheimer’s Disease
Zou, Z., Liu, C., Che, C., & Huang, H. (2014) · BioMed Research International · doi:10.1155/2014/291862 · Cited by 60
β-amyloid deposits in transgenic mice expressing human β-amyloid precursor protein have the same characteristics as those in Alzheimer's disease
Terai, K., Iwai, A., Kawabata, S., Tasaki, Y., Watanabe, T., Miyata, K., & Yamaguchi, T. (2001) · Neuroscience · doi:10.1016/s0306-4522(01)00095-1 · Cited by 58
YAC transgenics and the study of genetics and human disease
Lamb, B. T., & Gearhart, J. D. (1995) · Current Opinion in Genetics & Development · doi:10.1016/0959-437x(95)80049-2 · Cited by 59
Apoptosis, Neurotrophic Factors and Neurodegeneration
Dragunow, M., MacGibbon, G. A., Lawlor, P. A., Butterworth, N. J., Connor, B. J., Henderson, C. E., Walton, M. R., Woodgate, A.-M., Hughes, P. E., & Faull, R. L. M. (1997) · Reviews in the Neurosciences · doi:10.1515/revneuro.1997.8.3-4.223 · Cited by 58
Recent advancement in therapeutic strategies for Alzheimer’s disease: Insights from clinical trials
Khan, T., Waseem, R., Shahid, M., Ansari, J., Ahanger, I. A., Hassan, M. I., & Islam, A. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.102113 · Cited by 60
Overexpression of Heparanase Lowers the Amyloid Burden in Amyloid-β Precursor Protein Transgenic Mice
Jendresen, C., Hao, C., Zhang, X. L., Vlodavsky, I., Nilsson, L. N. G., & Li, J. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.600569 · Cited by 59
Differential Effects of the Swedish Mutant Amyloid Precursor Protein on β-Amyloid Accumulation and Secretion in Neurons and Nonneuronal Cells
Forman, M. S., Cook, D. G., Leight, S., Doms, R. W., & Lee, V. M. ‐. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.51.32247 · Cited by 57
ER stress is not elevated in the 5XFAD mouse model of Alzheimer's disease
Sadleir, K. R., Popović, J., & Vassar, R. J. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.005769 · Cited by 61
Deficient cerebral clearance of vasculotropic mutant Dutch/Iowa Double Aß in human AßPP transgenic mice
Davis, J., Xu, F., Miao, J., Previti, M. L., Romanov, G. A., Ziegler, K., & Nostrand, W. E. V. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.05.031 · Cited by 58
Genetics of Early-Onset Alzheimer Dementia
Rademakers, R., Cruts, M., & Broeckhoven, C. V. (2003) · The Scientific World JOURNAL · doi:10.1100/tsw.2003.39 · Cited by 58
A Large Swedish Family With Alzheimer's Disease With a Codon 670/671 Amyloid Precursor Protein Mutation
Axelman, K. (1994) · Archives of Neurology · doi:10.1001/archneur.1994.00540240037013 · Cited by 57
Self-citation
Chromosome 14 and late-onset familial Alzheimer disease (FAD).
Schellenberg, G. D., Payami, H., Wijsman, E. M., Orr, H. T., Goddard, K. A. B., Anderson, L., Nemens, E. J., White, J. A., Alonso, M. E., & Ball, M. J. (1993) · PubMed · Cited by 57
Defective neurite extension is caused by a mutation in amyloid ?/A4 (A?) protein precursor found in Familial Alzheimer's Disease
Li, H. L., Roch, J., Sundsmo, M. P., Otero, D. A. C., Sisodia, S. S., Thomas, R. G., & Saitoh, T. (1997) · Journal of Neurobiology · doi:10.1002/(sici)1097-4695(199705)32:5 · Cited by 58
The Potential of CRISPR/Cas9 Gene Editing as a Treatment Strategy for Alzheimer's Disease
Rohn, T. T., Kim, N., Isho, N. F., & Mack, J. M. (2018) · Journal of Alzheimer’s Disease & Parkinsonism · doi:10.4172/2161-0460.1000439 · Cited by 58
Tau is central in the genetic Alzheimer–frontotemporal dementia spectrum
Dermaut, B., Kumar‐Singh, S., Rademakers, R., Theuns, J., Cruts, M., & Broeckhoven, C. V. (2005) · Trends in Genetics · doi:10.1016/j.tig.2005.09.005 · Cited by 56
Cathepsin G: Localization in human cerebral cortex and generation of amyloidogenic fragments from the β-amyloid precursor protein
Savage, M. J., Iqbal, M., Loh, T., Trusko, S. P., Scott, R., & Siman, R. (1994) · Neuroscience · doi:10.1016/0306-4522(94)90490-1 · Cited by 42
Lack of association between apolipoprotein E allele ɛ4 and sporadic Alzheimer's disease
Lannfelt, L., Lilius, L., Nastase, M., Viitanen, M. H., Fratiglioni, L., Eggertsen, G., Berglund, L., Angelin, B., Linder, J., Winblad, B. G., et al. (1994) · Neuroscience Letters · doi:10.1016/0304-3940(94)90384-0 · Cited by 56
Self-citation
A Review of the Recent Advances in Alzheimer’s Disease Research and the Utilization of Network Biology Approaches for Prioritizing Diagnostics and Therapeutics
Hajjo, R., Sabbah, D. A., Abusara, O. H., & Bawab, A. Q. A. (2022) · Diagnostics · doi:10.3390/diagnostics12122975 · Cited by 57
Enhanced -secretase processing alters APP axonal transport and leads to axonal defects
Rodrigues, E. M., Weissmiller, A. M., & Goldstein, L. S. B. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds297 · Cited by 56
Detection of Cyclooxygenase-1 in Activated Microglia During Amyloid Plaque Progression: PET Studies in Alzheimer’s Disease Model Mice
Shukuri, M., Mawatari, A., Ohno, M., Suzuki, M., Doi, H., Watanabe, Y., & Onoe, H. (2015) · Journal of Nuclear Medicine · doi:10.2967/jnumed.115.166116 · Cited by 58
Functions of the Alzheimer’s Disease Protease BACE1 at the Synapse in the Central Nervous System
Munro, K. M., Nash, A., Pigoni, M., Lichtenthaler, S. F., & Gunnersen, J. M. (2016) · Journal of Molecular Neuroscience · doi:10.1007/s12031-016-0800-1 · Cited by 59
Primate-like amyloid-β sequence but no cerebral amyloidosis in aged tree shrews
Pawlik, M., Fuchs, E., Walker, L. C., & Levy, E. (1999) · Neurobiology of Aging · doi:10.1016/s0197-4580(99)00017-2 · Cited by 55
Comparative proteomic analysis using samples obtained with laser microdissection and saturation dye labelling
Wilson, K. E., Marouga, R., Prime, J. E., Pashby, D. P., Orange, P. R., Crosier, S., Keith, A. B., Lathe, R., Mullins, J. J., Estibeiro, P., et al. (2005) · PROTEOMICS · doi:10.1002/pmic.200401255 · Cited by 55
Alterations in β-amyloid production and deposition in brain regions of two transgenic models
Lehman, E. J. H., Kulnane, L. S., & Lamb, B. T. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00153-7 · Cited by 55
Clinical considerations in early-onset cerebral amyloid angiopathy
Banerjee, G., Collinge, J., Fox, N. C., Lashley, T., Mead, S., Schott, J. M., Werring, D. J., & Ryan, N. S. (2023) · Brain · doi:10.1093/brain/awad193 · Cited by 54
Evaluation of the poly(ADP‐ribose) polymerase‐1 gene variants in Alzheimer's disease
Liu, H., Lin, W., Wu, B., Liu, S. R., Wang, W., Tsai, C., Lee, C., & Tsai, F. (2010) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.20379 · Cited by 54
Mechanisms of neurodegeneration — Insights from familial Alzheimer’s disease
Chávez‐Gutiérrez, L., & Szaruga, M. (2020) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2020.03.005 · Cited by 59

Authors: Mullan, M., Crawford, F., Axelman, K., Houlden, H., Lilius, L., Winblad, B., & Lannfelt, L.
Affiliations: University of South Florida (US)
Karolinska Institutet (SE)
St Mary's Hospital (GB)
ORCID: Crawford, Fiona
Houlden, Henry
Winblad, Bengt
Lannfelt, Lars
Venue: Nature Genetics
Publisher: Springer Science and Business Media LLC
Published: 1992-08
Volume: 1
Issue: 5
Pages: 345-347
ISSN: 1061-4036 (ISSN-L)
1546-1718
DOI: 10.1038/ng0892-345
OpenAlex: W2030641075
Cited by: 1,513
References: 22
Citations by year: 2026: 24 · 2025: 30 · 2024: 50 · 2023: 47 · 2022: 49 · 2021: 46 · 2020: 52 · 2019: 56 · 2018: 48 · 2017: 48 · 2016: 47 · 2015: 31 · 2014: 62 · 2013: 31 · 2012: 32
FWCI: 49.77
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
Locations: Nature Genetics (publishedVersion)
PubMed (publishedVersion)
UCL Discovery (University College London) (submittedVersion)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
Keywords: Alzheimer's disease, APP gene, amyloid-beta, early-onset familial Alzheimer's disease, Swedish families
MeSH terms: Alzheimer Disease, Amino Acid Sequence, Base Sequence, Brain, Codon, Exons, Female, Humans, Genetic Linkage, Male, Middle Aged, Molecular Sequence Data, Oligodeoxyribonucleotides, Pedigree, Transcription, Genetic, Genetic Variation, Amyloid beta-Protein Precursor, Point Mutation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N–terminus of β–amyloid

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks